PUBLISHED DATE : Mar 2022 | Pages : 260
Fill out your details & get your free sample
The Insulin Pens Market Size, Share, Trends Analysis, Competitive Landscape, and Growth Potential by
260 Pages
69 Tables
125 Charts
5 Regions
19 Countries
17 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (2021) | USD 1.09 Billion |
| MARKET SIZE (2027) | USD 1.56 Billion |
| CAGR (2021-2027) | 6.26% |
| BASE YEAR | 2021 |
| FORECAST YEAR | 2022-2027 |
| MARKET SEGMENTS | Product (Traditional and Smart), Usage (Disposable and Reusable), Distribution Channel (Hospitals & Clinics, Standalone Pharmacies, and Online) |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| COUNTRIES COVERED | Germany, UK, France, Spain, Italy, US, Canada, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, South Africa, Saudi Arabia, UAE |
The insulin pens market is growing with a CAGR of 6.26% from 2021-2027 and is expected to reach USD 1.56 billion by 2027 from USD 1.09 billion in 2021. The high prevalence of diabetes across various healthcare settings and the subsequent rise in demand for insulin pens to manage diabetes have majorly contributed to the market growth in recent years. The global insulin pens market is also growing due to rising awareness among healthcare professionals and patients regarding insulin pen usage to manage diabetes better.
Various factors, such as unhealthy lifestyle practices, lead to increased obesity, thereby increasing the prevalence of diabetes worldwide. Insulin pens are delivery devices that deliver insulin under the skin for diabetic management. These are available in two types: disposable and refillable insulin pens. Due to the ease of usage and portable and handier nature the insulin pens, the demand is increasing worldwide. Recently, there has been an increase in the adoption of smart insulin pens in some regions, such as Europe and North America, and high-income countries in the APAC region, such as China. There is an increasing usage of insulin pens in ambulatory settings, mainly observed to be dominant in the US. In some countries in Europe, such as Spain, France, and Germany, doctors are prescribing insulin pens with health insurance coverage and a good cutting cost, which makes it more cost-effective than insulin syringes and vials, and highly convenient for the self-management of diabetes.
There is a high possibility of an increase in the adoption of smart insulin pens during the forecast period due to their long-term cost-effectiveness, along with other advantages such as accuracy, better convenience, and ease of use over conventional insulin pens and other traditional insulin delivery devices.
The advancements in the insulin pens include the introduction of smart insulin pens, which can be connected to the device that stores the history of insulin dosage and time, which helps the patients to manage their insulin dosing better. These smart insulin pens are revolutionizing the insulin pen market. A significant preference for diabetes pen usage is the accuracy in taking up the insulin doses, which is lacking in the syringes. Some of the limitations in insulin pen usage include increased frequency of administering the insulin by patients compared to insulin pumps.
Rise In The Diabetic Population To Boost The Market Growth
The constant rise in the diabetic population across the globe is one of the major drivers increasing the adoption of insulin pens. Insulin pen adoption is higher in developed countries compared to developing and underdeveloped countries. One of the significant limitations is the cost and lack of proper reimbursement, limiting the usage of diabetes pens across the countries. In addition, a large number of undiagnosed diabetic populations across the globe also limits the usage of insulin devices.
Insulin pen manufacturers invest in product launches, mainly in the smart insulin pen segment. For instance, Medtronic InPen (Bluetooth-enabled insulin pen) received FDA clearance in 2020 for all ages. NovoPen 6 -a smart insulin pen from Novo Nordisk in 2019 and more. The product launches were less from 2021 to 2022 due to the COVID-19 pandemic. It is expected to increase after the market resumes normal post-pandemic.
Impact Of COVID-19 On The Global Insulin Pen Market
COVID-19 had a neutral impact on the global insulin pen market. The demand was high as diabetic patients were high-risk populations for COVID-19 infection. This increased the pressure on diabetic patients to manage their health consciously. However, due to lockdown supply chain issues, the availability of diabetes pens was limited. Due to the economic pressure and job cuts during the large pandemic, patients shifted to using insulin syringes because of their affordable costs. This impacted the market negatively.
The traditional insulin pens are largely preferred due to their larger adoption and ease to use. These pens are still preferred among the elderly population (above 50 years) as they must attach the needle and inject it, which is prefilled and lasts for a longer time, with accurate dosing. Not many advancements are seen in the traditional diabetes injection devices as patients are already shifting towards the usage of smart insulin pens. However, the demand for smart insulin pens is increasing as they are more informative and help patients manage their health better. Smart insulin pens can streamline the data across multiple platforms like smart apps, blood glucose monitoring devices, etc. This helps them to manage diabetes in a better way.
Introduction of Low-Cost Insulin To Drive The Demand For Reusable Insulin Pens
Due to low maintenance and single usability, the demand for disposable insulin pens is growing. Re-usable insulin devices have the advantage that only refillable insulin cartridges need to be purchased and used. This reduces the cost of the total insulin pen cost. However, some companies are already working on manufacturing low-cost insulin; post-approval of low-cost insulin, the demand for re-usable diabetes pens might increase over disposable diabetes pens.
COVID-19 has Accelerated The Online Sales
Hospitals & clinics are the largest distribution channels in the global insulin pens market. Patients prefer purchasing diabetes pens from hospitals and clinics as they are the first point of contact for purchasing the product. Over time, the online channel is picking up the phase; there is a shift towards using online channels to purchase insulin pens in the market. The COVID-19 pandemic further accelerated the preference of online channels for purchasing insulin pens. There was a shortage and high chances of contracting COVID-19 infections in pharmacies and other healthcare settings.
Increasing Awareness Among Consumers To Push The APAC Insulin Pen Market Growth
Europe region dominated the insulin pen market by geography due to their higher adoption of insulin pens than syringes. The diabetes pens market in APAC posts a higher CAGR than other regions because of their increased target population, raising awareness regarding the insulin pens.
The North American region, especially the US considered one of the attractive markets for diabetic products, and many new companies are entering the market to attract customers. For instance, Biocon & Mylan launched a new insulin pen at an affordable cost in the US market compared to other existing products. This is expected to enhance competition among the vendors in the US insulin pen market landscape. Due to the lack of awareness and economic conditions, the Latin America & Middle East & Africa regions occupy a negligible insulin pens market share.
Frequently Asked Questions
What is the growth rate of the insulin pens market?
The growth rate of the insulin pens market is 6.26% in the forecast period
Which region has the highest growth rate in the insulin pens industry?
APAC region has the highest growth rate.
Who are the key players in the Insulin Pens industry?
The key players are Lilly, Medtronic, Novo Nordisk, and Sanofi.
Which segment of product type is dominating the injection pens market?
The traditional insulin pens segment is dominating the injection pens market.
What are some opportunities and trends in the insulin pens market?
Technological advancements in insulin pens, increased demand for smart insulin pens, and the rising prevalence of diabetes are some opportunities in the market.
The insulin pens market was valued at USD 1.1 billion in 2021 and is expected to reach USD 1.5 billion by 2027, growing at a CAGR of 6.26% during the forecast period
The following factors are likely to contribute to the growth of the insulin pens market-
Base Year: 2021
Forecast Year: 2022-2027
The study considers a detailed scenario of the present insulin pens market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
KEY VENDORS
OTHER PROMINENT VENDORS
Segmentation by Product
Segmentation by Usage
Segmentation by Distribution Channel
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY USAGE
4.3.3 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 MARKET OPPORTUNITIES & TRENDS
8.1 TECHNOLOGICAL ADVANCEMENTS IN INSULIN PENS
8.2 INCREASED DEMAND FOR SMART INSULIN PENS
8.3 INTRODUCTION OF INTEGRATED SMART PEN SYSTEMS
9 MARKET GROWTH ENABLERS
9.1 RISING PREVALENCE OF DIABETES
9.2 INCREASED USE OF INSULIN PENS IN AMBULATORY SETTINGS
9.3 GROWTH IN PRODUCT LAUNCHES
10 MARKET GROWTH RESTRAINTS
10.1 COMPLICATIONS ASSOCIATED WITH INSULIN PENS
10.2 HIGH COST & LACK OF UNIVERSAL INSURANCE COVERAGE
10.3 LARGE POPULATIONS WITH UNDIAGNOSED DIABETES
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 PRODUCT INSIGHTS
11.2.2 USAGE INSIGHTS
11.2.3 DISTRIBUTION CHANNEL INSIGHTS
11.2.4 GEOGRAPHY INSIGHTS
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 PRODUCT
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 TRADITIONAL INSULIN PENS
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 TRADITIONAL INSULIN PENS BY GEOGRAPHY
12.4 SMART INSULIN PENS
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 SMART INSULIN PENS BY GEOGRAPHY
13 USAGE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 DISPOSABLE INSULIN PENS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 DISPOSABLE INSULIN PENS BY GEOGRAPHY
13.4 REUSABLE INSULIN PENS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 REUSABLE INSULIN PENS BY GEOGRAPHY
14 DISTRIBUTION CHANNEL
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 HOSPITALS & CLINICS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 HOSPITALS & CLINICS BY GEOGRAPHY
14.4 STANDALONE PHARMACIES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 STANDALONE PHARMACIES BY GEOGRAPHY
14.5 ONLINE
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 ONLINE BY GEOGRAPHY
15 GEOGRAPHY
15.1 GEOGRAPHIC OVERVIEW
15.2 MARKET SNAPSHOT & GROWTH ENGINE
16 EUROPE
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.3 EUROPE: MARKET BY PRODUCT
16.4 EUROPE: MARKET BY USAGE
16.5 EUROPE: DISTRIBUTION CHANNEL
16.7 KEY COUNTRIES
16.7.1 GERMANY: MARKET SIZE & FORECAST
16.7.2 FRANCE: MARKET SIZE & FORECAST
16.7.3 UK: MARKET SIZE & FORECAST
16.7.4 ITALY: MARKET SIZE & FORECAST
16.7.5 SPAIN: MARKET SIZE & FORECAST
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 NORTH AMERICA: MARKET BY PRODUCT
17.4 NORTH AMERICA: MARKET BY USAGE
17.5 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNEL
17.7 KEY COUNTRIES
17.7.1 US: MARKET SIZE & FORECAST
17.7.2 CANADA: MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 APAC: MARKET BY PRODUCT
18.4 APAC: MARKET BY USAGE
18.5 APAC: MARKET BY DISTRIBUTION CHANNEL
18.6 KEY COUNTRIES
18.6.1 CHINA: MARKET SIZE & FORECAST
18.6.2 JAPAN: MARKET SIZE & FORECAST
18.6.3 INDIA: MARKET SIZE & FORECAST
18.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
18.6.5 AUSTRALIA: MARKET SIZE & FORECAST
19 LATIN AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 LATIN AMERICA: MARKET BY PRODUCT
19.4 LATIN AMERICA: MARKET BY USAGE
19.5 LATIN: MARKET BY DISTRIBUTION CHANNEL
19.6 KEY COUNTRIES
19.6.1 BRAZIL: MARKET SIZE & FORECAST
19.6.2 MEXICO: MARKET SIZE & FORECAST
19.6.3 ARGENTINA: MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 MIDDLE EAST & AFRICA: MARKET BY PRODUCT
20.4 MIDDLE EAST & AFRICA: MARKET BY USAGE
20.5 MIDDLE EAST & AFRICA: MARKET BY DISTRIBUTION CHANNEL
20.6 KEY COUNTRIES
20.6.1 TURKEY: MARKET SIZE & FORECAST
20.6.2 SOUTH AFRICA: MARKET SIZE & FORECAST
20.6.3 SAUDI ARABIA: MARKET SIZE & FORECAST
20.6.4 UAE: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
21.2 MARKET SHARE ANALYSIS
21.2.1 LILLY
21.2.2 MEDTRONIC
21.2.3 NOVO NORDISK
21.2.4 SANOFI
22 KEY COMPANY PROFILES
22.1 LILLY
22.1.1 BUSINESS OVERVIEW
22.1.2 PRODUCT OFFERINGS
22.1.3 KEY STRATEGIES
22.1.4 KEY STRENGTHS
22.1.5 KEY OPPORTUNITIES
22.2 MEDTRONIC
22.2.1 BUSINESS OVERVIEW
22.2.2 PRODUCT OFFERINGS
22.2.3 KEY STRATEGIES
22.2.4 KEY STRENGTHS
22.2.5 KEY OPPORTUNITIES
22.3 NOVO NORDISK
22.3.1 BUSINESS OVERVIEW
22.3.2 PRODUCT OFFERINGS
22.3.3 KEY STRATEGIES
22.3.4 KEY STRENGTHS
22.3.5 KEY OPPORTUNITIES
22.4 SANOFI
22.4.1 BUSINESS OVERVIEW
22.4.2 PRODUCT OFFERINGS
22.4.3 KEY STRATEGIES
22.4.4 KEY STRENGTHS
22.4.5 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
23.1 BD
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.2 BIOCON
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.3 EMPERRA GMBH E-HEALTH TECHNOLOGIES
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.4 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.5 HK ZION INDUSTRY
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.6 JIANGSU DELFU MEDICAL DEVICE
23.6.1 BUSINESS OVERVIEW
23.6.2 PRODUCT OFFERINGS
23.7 OWEN MUMFORD
23.7.1 BUSINESS OVERVIEW
23.7.2 PRODUCT OFFERINGS
23.8 PENDIQ
23.8.1 BUSINESS OVERVIEW
23.8.2 PRODUCT OFFERINGS
23.9 SHANGHAI UMITAI MEDICAL TECHNOLOGY
23.9.1 BUSINESS OVERVIEW
23.9.2 PRODUCT OFFERINGS
23.10 SUN MEDICAL PRODUCTS
23.10.1 BUSINESS OVERVIEW
23.10.2 PRODUCT OFFERINGS
23.11 SUZHOU PENG YE MEDICAL DEVICES
23.11.1 BUSINESS OVERVIEW
23.11.2 PRODUCT OFFERINGS
23.12 TRIONES TECHNOLOGY
23.12.1 BUSINESS OVERVIEW
23.12.2 PRODUCT OFFERINGS
23.13 YPSOMED
23.13.1 BUSINESS OVERVIEW
23.13.2 PRODUCT OFFERINGS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 MARKET BY GEOGRAPHY
25.2 MARKET BY PRODUCT
25.3 MARKET BY USAGE
25.4 MARKET BY DISTRIBUTION CHANNEL
25.5 NORTH AMERICA: MARKET BY PRODUCT
25.6 NORTH AMERICA: MARKET BY USAGE
25.7 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNEL
25.8 APAC: MARKET BY PRODUCT
25.9 APAC: MARKET BY USAGE
25.10 APAC: MARKET BY DISTRIBUTION CHANNEL
25.11 EUROPE: MARKET BY PRODUCT
25.12 EUROPE: MARKET BY USAGE
25.13 EUROPE: MARKET BY DISTRIBUTION CHANNEL
25.14 LATIN AMERICA: MARKET BY PRODUCT
25.15 LATIN AMERICA: MARKET BY USAGE
25.16 LATIN AMERICA: MARKET BY DISTRIBUTION CHANNEL
25.17 MIDDLE EAST & AFRICA: MARKET BY PRODUCT
25.18 MIDDLE EAST & AFRICA: MARKET BY USAGE
25.19 MIDDLE EAST & AFRICA: MARKET BY DISTRIBUTION CHANNEL
26 APPENDIX
26.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL INSULIN PENS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 PREVALENCE OF TYPE-2 DIABETES IN ADULTS (20-79 YEARS) 2019, 2030, & 2045 BY GEOGRAPHY
EXHIBIT 4 IMPACT OF TECHNOLOGICAL ADVANCEMENTS IN INSULIN PENS
EXHIBIT 5 IMPACT OF INCREASED DEMAND FOR SMART INSULIN PENS
EXHIBIT 6 TOTAL COST OF SMART INSULIN PENS & STANDARD CARE FOR NON-SEVERE HYPOGLYCEMIA IN SWEDEN ($)
EXHIBIT 7 IMPACT OF INTRODUCTION OF INTEGRATED SMART PEN SYSTEMS
EXHIBIT 8 IMPACT OF RISING PREVALENCE OF DIABETES
EXHIBIT 9 PREVALENCE OF DIABETES IN ADULTS (20-79 AGE GROUP) ACCORDING TO IDF
EXHIBIT 10 DEATHS OF DIABETIC POPULATION IN 20-79 AGE GROUP 2019
EXHIBIT 11 IMPACT OF INCREASING USAGE OF INSULIN PENS FOR AMBULATORY PURPOSES
EXHIBIT 12 IMPACT OF GROWTH IN PRODUCT LAUNCHES
EXHIBIT 13 IMPACT OF COMPLICATIONS ASSOCIATED WITH INSULIN PENS
EXHIBIT 14 IMPACT OF HIGH COST & LACK OF UNIVERSAL INSURANCE COVERAGE
EXHIBIT 15 IMPACT OF LARGE POPULATIONS WITH UNDIAGNOSED DIABETES
EXHIBIT 16 GLOBAL UNDIAGNOSED DIABETES POPULATION AGED BETWEEN 20-79 (%)
EXHIBIT 17 GLOBAL INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 18 GLOBAL INSULIN PENS MARKET SHARE BY PRODUCT 2021 & 2027 (%)
EXHIBIT 19 GLOBAL INSULIN PENS MARKET SHARE BY USAGE 2021 & 2027 (%)
EXHIBIT 20 GLOBAL INSULIN PENS MARKET SHARE BY DISTRIBUTION CHANNEL 2021 & 2027 (%)
EXHIBIT 21 GLOBAL INSULIN PENS MARKET SHARE BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 22 FIVE FORCES ANALYSIS 2021
EXHIBIT 23 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 24 GLOBAL INSULIN PENS MARKET BY PRODUCT TYPE
EXHIBIT 25 GLOBAL INSULIN PENS MARKET BY PRODUCT: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 26 GLOBAL INSULIN PENS MARKET BY PRODUCT: ABSOLUTE GROWTH (%)
EXHIBIT 27 ADVANTAGES OF INSULIN PENS OVER SYRINGES
EXHIBIT 28 SOME TRADITIONAL INSULIN PENS OFFERED BY NOVO NORDISK
EXHIBIT 29 GLOBAL TRADITIONAL INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 30 GLOBAL TRADITIONAL INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 31 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 32 GLOBAL SMART INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 33 GLOBAL SMART INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 34 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 35 INCREMENTAL GROWTH BY USAGE 2021 & 2027
EXHIBIT 36 GLOBAL INSULIN PENS MARKET BY USAGE
EXHIBIT 37 GLOBAL INSULIN PENS MARKET BY USAGE: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 38 GLOBAL DISPOSABLE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL DISPOSABLE INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 40 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 41 GLOBAL REUSABLE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL REUSABLE INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 44 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL BY 2021 & 2027
EXHIBIT 45 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL
EXHIBIT 46 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 47 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL: ABSOLUTE GROWTH (%)
EXHIBIT 48 GLOBAL INSULIN PENS MARKET BY HOSPITALS & CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL HOSPITALS & CLINICS INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 51 GLOBAL INSULIN PENS MARKET BY STANDALONE PHARMACIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL STANDALONE PHARMACIES INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 53 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 54 GLOBAL ONLINE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL ONLINE INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 56 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 57 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY
EXHIBIT 58 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 59 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 61 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 62 EUROPE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 63 EUROPE INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)
EXHIBIT 64 EUROPE INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 65 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 66 INCREMENTAL GROWTH BY USAGE 2021 & 2027
EXHIBIT 67 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 68 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 69 INSULIN PENS MARKET IN GERMANY 2021–2027 ($ MILLION)
EXHIBIT 70 INSULIN PENS MARKET IN FRANCE 2021–2027 ($ MILLION)
EXHIBIT 71 INSULIN PENS MARKET IN UK 2021–2027 ($ MILLION)
EXHIBIT 72 INSULIN PENS MARKET IN ITALY 2021–2027 ($ MILLION)
EXHIBIT 73 INSULIN PENS MARKET IN SPAIN 2021–2027 ($ MILLION)
EXHIBIT 74 NORTH AMERICA INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)
EXHIBIT 75 NORTH AMERICA INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 76 NORTH AMERICA INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 77 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 78 INCREMENTAL GROWTH BY USAGE 2021 & 2027
EXHIBIT 79 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 80 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 81 INSULIN PENS MARKET IN US 2021–2027 ($ MILLION)
EXHIBIT 82 INSULIN PENS MARKET IN CANADA 2021–2027 ($ MILLION)
EXHIBIT 83 APAC INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 84 APAC INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)
EXHIBIT 85 APAC INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 86 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 87 INCREMENTAL GROWTH BY USAGE 2021 & 2027
EXHIBIT 88 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 89 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 90 INSULIN PENS MARKET IN CHINA 2021–2027 ($ MILLION)
EXHIBIT 91 INSULIN PENS MARKET IN JAPAN 2021–2027 ($ MILLION)
EXHIBIT 92 INSULIN PENS MARKET IN INDIA 2021–2027 ($ MILLION)
EXHIBIT 93 INSULIN PENS MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)
EXHIBIT 94 INSULIN PENS MARKET IN AUSTRALIA 2021–2027 ($ MILLION)
EXHIBIT 95 LATIN AMERICA INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 96 LATIN AMERICA INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)
EXHIBIT 97 LATIN AMERICA INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 98 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 99 INCREMENTAL GROWTH BY USAGE 2021 & 2027
EXHIBIT 100 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 101 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 102 INSULIN PENS MARKET IN BRAZIL 2021–2027 ($ MILLION)
EXHIBIT 103 INSULIN PENS MARKET IN MEXICO 2021–2027 ($ MILLION)
EXHIBIT 104 INSULIN PENS MARKET IN ARGENTINA 2021–2027 ($ MILLION)
EXHIBIT 105 MIDDLE EAST & AFRICA INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 106 MIDDLE EAST & AFRICA INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)
EXHIBIT 107 MIDDLE EAST & AFRICA INSULIN PENS MARKET 2021–2027 ($ MILLION)
EXHIBIT 108 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 109 INCREMENTAL GROWTH BY USAGE 2021 & 2027
EXHIBIT 110 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027
EXHIBIT 111 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 112 INSULIN PENS MARKET IN TURKEY 2021–2027 ($ MILLION)
EXHIBIT 113 INSULIN PENS MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)
EXHIBIT 114 INSULIN PENS MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)
EXHIBIT 115 INSULIN PENS MARKET IN UAE 2021–2027 ($ MILLION)
EXHIBIT 116 LILLY: MARKET SHARE BY GEOGRAPHY 2020 (%)
EXHIBIT 117 LILLY: TOTAL REVENUE 2018-2020 ($ MILLION)
EXHIBIT 118 MEDTRONIC: TOTAL REVENUE BY DIABETES CARE SEGMENT 2018–2020 ($ MILLION)
EXHIBIT 119 MEDTRONIC: MARKET SHARE OF DIABETES CARE BY GEOGRAPHY (%)
EXHIBIT 120 NOVO NORDISK: MARKET SHARE BY GEOGRAPHY 2020 (%)
EXHIBIT 121 NOVO NORDISK: MARKET SHARE BY SEGMENTS 2020 (%)
EXHIBIT 122 NOVO NORDISK: REVENUE 2019–2020 ($ BILLION)
EXHIBIT 123 SANOFI: MARKET SHARE BY SEGMENTS 2020 (%)
EXHIBIT 124 SANOFI: TOTAL REVENUE BY PHARMACEUTICAL SEGMENT 2018–2020 ($ MILLION)
EXHIBIT 125 SANOFI: MARKET SHARE OF PHARMACEUTICAL SEGMENT BY GEOGRAPHY 2020 (%)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 ADVANTAGES & DISADVANTAGES OF INSULIN PENS
TABLE 4 OVERVIEW OF INSULIN PEN ATTACHMENTS
TABLE 5 KEY ADVANCED INSULIN PENS IN MARKET
TABLE 6 OVERVIEW OF SMART CAPS
TABLE 7 GLOBAL DIABETES MARKET SIZE ($ MILLION)
TABLE 8 FACTORS INCREASING DIABETES PREVALENCE WORLDWIDE
TABLE 9 INSULIN PENS LAUNCHED IN RECENT YEARS
TABLE 10 AVERAGE PRICE OF INSULIN PENS & INSULIN VIALS PER PACKAGE & PER MONTH
TABLE 11 TRADITIONAL INSULIN PENS OFFERED BY OTHER COMPANIES
TABLE 12 SMART INSULIN PENS FROM VARIOUS COMPANIES
TABLE 13 LIST OF COMMONLY USED DISPOSABLE INSULIN PENS
TABLE 14 LIST OF COMMONLY USED REUSABLE INSULIN PENS
TABLE 15 LILLY: MAJOR PRODUCT OFFERINGS
TABLE 16 MEDTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 17 NOVO NORDISK: MAJOR PRODUCT OFFERINGS
TABLE 18 SANOFI: MAJOR PRODUCT OFFERINGS
TABLE 19 BD: MAJOR PRODUCT OFFERINGS
TABLE 20 BIOCON: MAJOR PRODUCT OFFERINGS
TABLE 21 EMPERRA GMBH E-HEALTH TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 22 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT: MAJOR PRODUCT OFFERINGS
TABLE 23 HK ZION INDUSTRY: MAJOR PRODUCT OFFERINGS
TABLE 24 JIANGSU DELFU MEDICAL DEVICE: MAJOR PRODUCT OFFERINGS
TABLE 25 OWEN MUMFORD: MAJOR PRODUCT OFFERINGS
TABLE 26 PENDIQ: MAJOR PRODUCT OFFERINGS
TABLE 27 SHANGHAI UMITAI MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 28 SUN MEDICAL PRODUCTS: MAJOR PRODUCT OFFERINGS
TABLE 29 SUZHOU PENG YE MEDICAL DEVICES: MAJOR PRODUCT OFFERINGS
TABLE 30 TRIONES TECHNOLOGY (GUANGZHOU): MAJOR PRODUCT OFFERINGS
TABLE 31 YPSOMED: MAJOR PRODUCT OFFERINGS
TABLE 32 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 33 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 34 GLOBAL INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)
TABLE 35 GLOBAL INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)
TABLE 36 GLOBAL INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)
TABLE 37 GLOBAL INSULIN PENS MARKET BY USAGE 2021-2027 (%)
TABLE 38 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
TABLE 39 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
TABLE 40 NORTH AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)
TABLE 41 NORTH AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)
TABLE 42 NORTH AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)
TABLE 43 NORTH AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 (%)
TABLE 44 NORTH AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
TABLE 45 NORTH AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
TABLE 46 APAC INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)
TABLE 47 APAC INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)
TABLE 48 APAC INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)
TABLE 49 APAC INSULIN PENS MARKET BY USAGE 2021-2027 (%)
TABLE 50 APAC INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
TABLE 51 APAC INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
TABLE 52 EUROPE INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)
TABLE 53 EUROPE INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)
TABLE 54 EUROPE INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)
TABLE 55 EUROPE INSULIN PENS MARKET BY USAGE 2021-2027 (%)
TABLE 56 EUROPE INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
TABLE 57 EUROPE INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
TABLE 58 LATIN AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)
TABLE 59 LATIN AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)
TABLE 60 LATIN AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)
TABLE 61 LATIN AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 (%)
TABLE 62 LATIN AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
TABLE 63 LATIN AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
TABLE 64 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)
TABLE 65 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)
TABLE 66 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)
TABLE 67 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY USAGE 2021-2027 (%)
TABLE 68 MIDDLE EAST & AFRICA MARKET INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)
TABLE 69 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
